摘要
慢性肾脏病(CKD)已成为全球危害人类健康的重要公共卫生问题。我国成人CKD患病率为10.8%,但人群知晓率和诊断率普遍较低。我国尚未建立规范的CKD筛查体系与标准诊疗路径。因此,加强CKD防控,推进疾病管理已迫在眉睫。本指南由中华预防医学会肾脏病预防与控制专业委员会发起,采用牛津证据分级系统对相关证据质量和推荐强度进行分级,制订了38条推荐意见,旨在规范CKD的早期筛查、管理与诊疗,推动我国肾脏疾病的医防融合研究与实践。
Chronic kidney disease(CKD)has become a serious public health concern that endangers human health on a global scale.In China,the prevalence of CKD in adults is 10.8%;however,public awareness and the diagnostic rates of CKD in the Chinese population are relatively low.Moreover,China has not yet established a national CKD screening system or developed standardized diagnostic protocols and treatment pathways.Therefore,there is an urgent need to strengthen the prevention and control of CKD and promote the management of this disease.These guidelines were initiated by the Chinese Preventive Medicine Association for Kidney Disease.The quality of evidence and guideline recommendation were determined by applying the Oxford Centre for Evidence-Based Medicine(CEBM)System.These new guidelines describe 38 recommendations that aim to standardize the early screening,management,diagnosis and treatment of CKD,thus promoting the integrated prevention and control of kidney disease in China.
作者
华预防医学会肾脏病预防与控制专业委员会
张路霞
赵明辉
Chinese Preventive Medicine Association for Kidney Disease;Zhang Luxia;Zhao Minghui(不详;National Institute of Health Data Science at Peking University,Beijing 100191,China;Renal Division,Department of Medicine,Peking University First Hospital,Peking University Institute of Nephrology,Beijing 100034,China)
出处
《中华内科杂志》
CAS
CSCD
北大核心
2023年第8期902-930,共29页
Chinese Journal of Internal Medicine
关键词
慢性肾脏病
指南
评价
管理
预防
Chronic kidney disease
Guidelines
Evaluation
Management
Prevention
